Quantitative Volumetric CT-Histogram Analysis in N-Staging of 18F-FDG–Equivocal Patients with Lung Cancer

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Nuclear Medicine

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2967/jnumed.113.128504PMID 24525209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer

  2013cited by this paper
• Imaging of Metastatic Lymph Nodes by X-ray Phase-Contrast Micro-Tomography

  2013cited by this paper
• Lung, Liver and Lymph Node Metastases in Follow-Up MSCT: Comprehensive Volumetric Assessment of Lesion Size Changes

  2012cited by this paper
• Mediastinal staging of lung cancer: novel concepts.

  2012cited by this paper
• Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy--a retrospective study.

  2012cited by this paper
• Invasive staging of mediastinal lymph nodes: mediastinoscopy and remediastinoscopy.

  2012cited by this paper
• Value of 4-Dimensional 18F-FDG PET/CT in the Classification of Pulmonary Lesions

  2011cited by this paper
• Semi-automated volumetric analysis of lymph node metastases during follow-up—initial results

  2011cited by this paper
• Usefulness of semi-automatic volumetry compared to established linear measurements in predicting lymph node metastases in MSCT

  2011cited by this paper
• Prediction of Lymph Node Manifestations in Malignant Lymphoma: Significant Role of Volumetric Compared With Established Metric Lymph Node Analysis in Multislice Computed Tomography

  2010cited by this paper
• Semiautomatic Lymph Node Segmentation in Multislice Computed Tomography: Impact of Slice Thickness on Segmentation Quality, Measurement Precision, and Interobserver Variability

  2010cited by this paper
• Prediction of lymph node metastases in NSCLC. Three dimensional anatomical parameters do not substitute FDG-PET-CT.

  2010cited by this paper
• Einsatz der PET/CT zur Diagnostik und Therapiestratifizierung des Bronchialkarzinoms

  2010cited by this paper
• FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer

  2009cited by this paper
• Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)

  2009cited by this paper
• Advanced Segmentation Techniques for Lung Nodules, Liver Metastases, and Enlarged Lymph Nodes in CT Scans

  2009influential reference
• New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

  2009cited by this paper
• Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).

  2007cited by this paper
• [Follow-up CT measurement of liver malignoma according to RECIST and WHO vs. volumetry].

  2007cited by this paper
• Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study

  2007cited by this paper
• Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer.

  2005cited by this paper
• The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival.

  2005cited by this paper
• Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?

  2004cited by this paper
• Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

  2003cited by this paper
• Noninvasive staging of non-small cell lung cancer: a review of the current evidence.

  2003cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors

  2000cited by this paper
• Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• CT demonstration of the 1996 AJCC-UICC regional lymph node classification for lung cancer staging.

  1999cited by this paper
• Reporting results of cancer treatment

  1981cited by this paper
• Treatment

  1973cited by this paper

• Predicting the immune therapy response of advanced non-small cell lung cancer based on primary tumor and lymph node radiomics features

  2025cites this paper
• CT features and histogram analysis of non-contrast images for differentiating malignant and benign mediastinal lymph nodes in Non-Small Cell Lung Cancer (NSCLC)

  2025cites this paper
• Clinical evaluation of deep learning‐enhanced lymphoma pet imaging with accelerated acquisition

  2024cites this paper
• The Effect of Hounsfield Unit Value on the Differentiation of Malignant/Benign Mediastinal Lymphadenopathy and Masses Diagnosed by Endobronchial Ultrasonography

  2024cites this paper
• Mask R-CNN assisted 2.5D object detection pipeline of 68Ga-PSMA-11 PET/CT-positive metastatic pelvic lymph node after radical prostatectomy from solely CT imaging

  2023cites this paper
• Läsionen des viszeralen Mediastinums

  2023cites this paper
• The efficacy of volumetric computed tomography histogram analysis in adrenal masses

  2023cites this paper
• Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning

  2022cites this paper
• Dual-Layer Spectral Detector CT in Comparison with FDG-PET/CT for the Assessment of Lymphoma Activity.

  2022cites this paper
• Pre-Operative Prediction of Mediastinal Node Metastasis Using Radiomics Model Based on 18F-FDG PET/CT of the Primary Tumor in Non-Small Cell Lung Cancer Patients

  2021cites this paper
• Precision diagnosis based on radiomics

  2021cites this paper
• A PET/CT nomogram incorporating SUVmax and CT radiomics for preoperative nodal staging in non-small cell lung cancer

  2021cites this paper
• Is it possible to achieve more accurate mediastinal nodal radiotherapy planning for NSCLC with PET/CT?

  2020influential citation
• A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients

  2020cites this paper
• Prediction of mediastinal lymph node metastasis based on 18F-FDG PET/CT imaging using support vector machine in non-small cell lung cancer

  2020cites this paper
• PET/CT Imaging of NSCLC with a αvβ6 Integrin-Targeting Peptide

  2019cites this paper
• Role of CT Density in PET/CT-Based Assessment of Lymphoma

  2018cites this paper
• Impact of Computer-Aided CT and PET Analysis on Non-invasive T Staging in Patients with Lung Cancer and Atelectasis

  2018cites this paper
• Diagnostic Imaging and Newer Modalities for Thoracic Diseases: PET/Computed Tomographic Imaging and Endobronchial Ultrasound for Staging and Its Implication for Lung Cancer.

  2018cites this paper
• Metastatic diagnosis of canine sternal lymph nodes using computed tomography characteristics: A retrospective cross‐sectional study

  2018cites this paper
• Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD

  2018cites this paper
• Impact of FDG-PET and Dynamic Contrast-Enhanced MRI in Comparison with DWI for N-Staging in Lung Cancer Patients

  2018cites this paper
• Diagnostic Imaging and Newer Modalities for Thoracic Diseases: PET/Computed Tomographic Imaging and Endobronchial Ultrasound for Staging and Its Implication for Lung Cancer.

  2017cites this paper
• Correlation Between SUVmax and CT Radiomic Analysis Using Lymph Node Density in PET/CT-Based Lymph Node Staging

  2017cites this paper
• Radiomic Analysis using Density Threshold for FDG-PET/CT-Based N-Staging in Lung Cancer Patients

  2017influential citation
• Predicting the nodal status in gastric cancers: The role of apparent diffusion coefficient histogram characteristic analysis.

  2017cites this paper
• Three-dimensional substructure measurements for the differential diagnosis of ground glass nodules

  2017cites this paper
• Pulmonary ground-glass nodules diagnosis: mean change rate of peak CT number as a discriminative factor of pathology during a follow-up.

  2016cites this paper
• The diagnostic ability of 18F-FDG PET/CT for mediastinal lymph node staging using 18F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer

  2016influential citation
• Watch the weathercock: changes in re-staging 18F-FDG PET/CT scan predict the probability of relapse in locally advanced non-small cell lung cancer

  2016cites this paper
• Follow-up FDG PET/CT in Patients With Non-Hodgkin Lymphoma: Value to Clinical Assessment and Patient Management

  2016cites this paper
• CT radiomic analysis using lymph-node-density profile in correlation to SUV-value for PET/CT based N-Staging

  2016cites this paper
• Increased x-ray attenuation in malignant vs. benign mediastinal nodes in an orthotopic model of lung cancer.

  2015cites this paper
• PET/MRI and PET/CT in Lung Lesions and Thoracic Malignancies.

  2015cites this paper